Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA
18 avr. 2024 08h00 HE
|
Volta Medical
• Demonstration of Volta AF-Xplorer™ at Heart Rhythm Society (HRS) 2024, May 16-19• Dr. Andrea Natale, a world recognized leader in the field of electrophysiology, to moderate Rhythm Theater ...
Volta Medical Receives CE Mark for AF-Xplorer™ Decision support solution to Simplify Complex Atrial Fibrillation Procedures
28 févr. 2024 08h00 HE
|
Volta Medical
Proprietary AI companion technology assists electrophysiologists by reducing ambiguity in mapped atrial fibrillation (AF) patterns MARSEILLE, France, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Volta...
Volta Medical Named Best Startup at Prix Galien USA Awards 2023
02 nov. 2023 08h00 HE
|
Volta Medical
MARSEILLE, France, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologist physicians...
Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation
22 juin 2023 08h00 HE
|
Volta Medical
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablationInternational, multi-center trial at 21 sites with...
Volta Medical Announces FDA Clearance of Volta AF-Xplorer™ Software to Simplify Complex Atrial Fibrillation Procedures
18 mai 2023 17h00 HE
|
Volta Medical
• Live demonstration of new software at Heart Rhythm Society (HRS) 2023, May 19-21 MARSEILLE, France, May 18, 2023 (GLOBE NEWSWIRE) -- Volta Medical, a pioneering health technology company...
Volta Medical Announces Completion of Patient Enrollment in TAILORED-AF Clinical Trial for Treatment of Atrial Fibrillation
02 févr. 2023 08h00 HE
|
Volta Medical
• First randomized controlled clinical trial to evaluate VX1-guided ablation compared to conventional anatomical ablation approaches to treat persistent atrial fibrillation• International,...
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced
05 janv. 2023 08h00 HE
|
Volta Medical
New round of financing led by Vensana Capital will support technology platform expansion and further validating VX1, Volta’s Artificial Intelligence (AI) Decision-Support Software in improving...
Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication
31 août 2022 08h00 HE
|
Volta Medical
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent...
Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022
27 avr. 2022 08h00 HE
|
Volta Medical
- Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress - MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) -- Volta...
First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis
21 déc. 2021 08h00 HE
|
Volta Medical
Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in patients undergoing ablation treatment for persistent, drug-resistant atrial...